Merry Life Biomedical Company announces the launch of its global Phase II clinical trial for TML-6, a novel oral small molecule drug targeting early-stage Alzheimer’s disease (AD). TML-6 combines multiple mechanisms, including anti-oxidative effects (Nrf2 activation), melioration of autophagy function (autolysosomal activation), anti-amyloid accumulation (?-amyloid clearance), and anti-inflammatory effects (through NF-?B inhibition) through autolysosome pathway in neurons and microglia to remove intraneuronal and extracellular amyloid accumulation, representing the first in human multi-target strategy for AD treatment. The Phase I trial showed excellent safety, tolerability, and pharmacokinetics at 100–200 mg in both healthy and elderly adults. TML-6 will now advance to a Phase II 19 site trial across the United States, Sweden, and Taiwan after FDA approval. This 12-month study will enroll 210 patients with mild cognitive impairment (MCI) or mild dementia. Primary endpoints will include neuropsychological assessments (CDR-SB, iADRS) and… 

BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) announced today that the interim safety review of the clinical Phase 2a study EXIST showed exidavnemab to be safe and well-tolerated, whereby the second dose cohorts will now be initiated. The EXIST study evaluates exidavnemab, a drug candidate being developed as a treatment for Parkinson’s disease and Multiple System Atrophy (MSA). The first cohort in the ongoing clinical Phase 2a study EXIST evaluated a lower dose of exidavnemab compared to placebo in patients with Parkinson’s disease. An interim safety review showed that exidavnemab was safe and well tolerated. The positive outcome will result in the initiation of two further cohorts, to evaluate a higher dose of exidavnemab in comparison with placebo in patients with Parkinson’s disease as well as MSA.

英伟达与德国电信将在德国本土为欧洲制造商建立全球首个工业人工智能云。一方面，这将为人工智能超级工厂铺平道路；另一方面，它也为通过快速实施人工智能来推动德国的工业地位并建立竞争优势提供了机会。工业人工智能云的实施应不迟于 2026 年完成。英伟达的尖端技术，电信的安全基础设施 人工智能工厂将支持欧洲制造商的工业人工智能工作负载。它将拥有超过 10,000 个 GPU。为此，英伟达 DGX B200 系统和 RTX Pro 服务器 GPU 将提供支持，这些 GPU 上运行着来自领先软件供应商的英伟达 CUDA-X、RTX 和 Omniverse 加速工作负载。德国电信提供其安全、主权和快速的基础设施，并负责数据中心、运营、销售以及安全和人工智能解决方案。此外，它保证欧洲的价值观，如数据保护和数据安全得到遵守，并且数据仅…